Here are three things to know.
1. Mr. Dvorak, who served as CEO for ten years, also stepped down from the company’s board of directors.
2. Daniel P. Florin, Zimmer Biomet’s senior vice president and CFO, will serve as interim CEO and fill Mr. Dvorak’s seat on the board until a permanent replacement is named.
3. Mr. Dvorak will also act as a company advisor for a short time to assist in the leadership transition.
“Serving alongside Zimmer Biomet’s dedicated employees over the past 16 years and leading the company as CEO for ten of those years has been a privilege and a highlight of my professional career,” said Mr. Dvorak. “I am particularly proud of what we have accomplished working together with surgeons and clinicians to help millions of patients globally improve their quality of life.”
More articles on supply chain:
How Trump’s efforts to lower drug prices affect the industry — 4 questions on a possible executive order
Suburban Hospital wants to compete with MedStar Georgetown for liver transplants
Why supply chain leaders should practice unlearning
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
